2 Final decisions made pursuant to regulation 4ZCZR - proposals referred to the November 2019 Joint Advisory Committee on Medicines and Chemicals Scheduling (ACCS-ACMS #23)
2.2. Final decision in relation to N-methyl-2-pyrrolidone (NMP)
Pursuant to regulation 42ZCZR of the Regulations, a Delegate of the Secretary has made a final decision to affirm the interim decision and not amend the current Poisons Standard in relation to N-methyl-2-pyrrolidone (NMP).
Reasons for the final decision (including findings on material questions of fact)
I confirm that the reasons for my final decision not to amend the Poison Standard with respect to NMP are as detailed in my second interim decision. In making my final decision. I have taken into account the material detailed in the interim decision and have noted that no public submissions were received before the second closing date in response to the call for further submissions published on 6 February 2020 under regulation 42ZCZP of the Regulations.
Summary of public submissions on the interim decision
No public submissions were received in response to the second interim decision.
Date of effect of the decision
7 May 2020
The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.